174 related articles for article (PubMed ID: 26100992)
1. Spectrum of Histopathological Findings in Live Donor Liver Graft Biopsies.
Tariq H; Nasir H
J Coll Physicians Surg Pak; 2015 Jun; 25(6):412-6. PubMed ID: 26100992
[TBL] [Abstract][Full Text] [Related]
2. Comparison of histopathology in acute allograft rejection and recurrent hepatitis C infection after liver transplantation.
Petrovic LM; Villamil FG; Vierling JM; Makowka L; Geller SA
Liver Transpl Surg; 1997 Jul; 3(4):398-406. PubMed ID: 9346770
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis C recurrence is not adversely affected by the use of donation after cardiac death liver allografts.
Tao R; Ruppert K; Cruz RJ; Malik SM; Shaikh O; Ahmad J; DiMartini A; Humar A; Fontes PA; de Vera ME
Liver Transpl; 2010 Nov; 16(11):1288-95. PubMed ID: 21031544
[TBL] [Abstract][Full Text] [Related]
4. C4d in acute rejection after liver transplantation and its usefulness in differential diagnosis between acute liver rejection and hepatitis C recurrence.
Gierej B; Kobryń K; Gierej P; Górnicka B
Ann Transplant; 2014 Aug; 19():373-81. PubMed ID: 25082343
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of chronic HCV infection in transplanted livers using a modified histological activity index.
Ziarkiewicz-Wroblewska B; Wroblewski T; Ziolkowski J; Cieslak B; Oldakowska-Jedynak U; Mucha K; Foroncewicz B; Paczek L; Krawczyk M; Malejczyk J; Zimmermann A
Ann Transplant; 2011; 16(1):26-33. PubMed ID: 21436771
[TBL] [Abstract][Full Text] [Related]
6. Characterization of CD4, CD8, CD56 positive lymphocytes and C4d deposits to distinguish acute cellular rejection from recurrent hepatitis C in post-liver transplant biopsies.
Jain A; Ryan C; Mohanka R; Orloff M; Abt P; Romano J; Bryan L; Batzold P; Mantry P; Bozorgzadeh A
Clin Transplant; 2006; 20(5):624-33. PubMed ID: 16968489
[TBL] [Abstract][Full Text] [Related]
7. Use of OKT3 is associated with early and severe recurrence of hepatitis C after liver transplantation.
Rosen HR; Shackleton CR; Higa L; Gralnek IM; Farmer DA; McDiarmid SV; Holt C; Lewin KJ; Busuttil RW; Martin P
Am J Gastroenterol; 1997 Sep; 92(9):1453-7. PubMed ID: 9317061
[TBL] [Abstract][Full Text] [Related]
8. ELISA-based detection of C4d after liver transplantation--a helpful tool for differential diagnosis between acute rejection and HCV-recurrence?
Schmeding M; Kienlein S; Röcken C; Neuhaus R; Neuhaus P; Heidenhain C; Neumann UP
Transpl Immunol; 2010 Aug; 23(4):156-60. PubMed ID: 20558292
[TBL] [Abstract][Full Text] [Related]
9. Histological and clinical outcome after liver transplantation for hepatitis C.
Shuhart MC; Bronner MP; Gretch DR; Thomassen LV; Wartelle CF; Tateyama H; Emerson SS; Perkins JD; Carithers RL
Hepatology; 1997 Dec; 26(6):1646-52. PubMed ID: 9398011
[TBL] [Abstract][Full Text] [Related]
10. Killer cell immunoglobulin-like receptor genotype and killer cell immunoglobulin-like receptor-human leukocyte antigen C ligand compatibility affect the severity of hepatitis C virus recurrence after liver transplantation.
de Arias AE; Haworth SE; Belli LS; Burra P; Pinzello G; Vangeli M; Minola E; Guido M; Boccagni P; De Feo TM; Torelli R; Cardillo M; Scalamogna M; Poli F
Liver Transpl; 2009 Apr; 15(4):390-9. PubMed ID: 19326408
[TBL] [Abstract][Full Text] [Related]
11. Hepatocellular MxA protein expression supports the differentiation of recurrent hepatitis C disease from acute cellular rejection after liver transplantation.
MacQuillan GC; de Boer WB; Allan JE; Platten MA; Reed WD; Jeffrey GP
Clin Transplant; 2010; 24(2):252-8. PubMed ID: 19712085
[TBL] [Abstract][Full Text] [Related]
12. A prospective evaluation of fibrosis progression in patients with recurrent hepatitis C virus following liver transplantation.
Yilmaz N; Shiffman ML; Stravitz RT; Sterling RK; Luketic VA; Sanyal AJ; Mills AS; Contos MJ; Coterell A; Maluf D; Posner MP; Fisher RA
Liver Transpl; 2007 Jul; 13(7):975-83. PubMed ID: 17600360
[TBL] [Abstract][Full Text] [Related]
13. High incidence of allograft cirrhosis in hepatitis C virus genotype 1b infection following transplantation: relationship with rejection episodes.
Prieto M; Berenguer M; Rayón JM; Córdoba J; Argüello L; Carrasco D; García-Herola A; Olaso V; De Juan M; Gobernado M; Mir J; Berenguer J
Hepatology; 1999 Jan; 29(1):250-6. PubMed ID: 9862874
[TBL] [Abstract][Full Text] [Related]
14. Evolution of hepatitis C virus in liver allografts.
Demetris AJ
Liver Transpl; 2009 Nov; 15 Suppl 2():S35-41. PubMed ID: 19876940
[TBL] [Abstract][Full Text] [Related]
15. Change in composition of inflammatory infiltrate in the course of hepatitis C reinfection and concomitant acute rejection after orthotopic liver transplantation.
Ziarkiewicz-Wróblewska B; Wróblewski T; Ciszek M; Kalinowski P; Malejczyk J
Ann Transplant; 2014 Jan; 19():41-50. PubMed ID: 24457607
[TBL] [Abstract][Full Text] [Related]
16. Natural history of post-liver transplantation hepatitis C: A review of factors that may influence its course.
Gallegos-Orozco JF; Yosephy A; Noble B; Aqel BA; Byrne TJ; Carey EJ; Douglas DD; Mulligan D; Moss A; de Petris G; Williams JW; Rakela J; Vargas HE
Liver Transpl; 2009 Dec; 15(12):1872-81. PubMed ID: 19938138
[TBL] [Abstract][Full Text] [Related]
17. Rapidly progressive recurrent hepatitis C virus infection starting 9 days after liver transplantation.
Saraf N; Fiel MI; Deboccardo G; Emre S; Schiano TD
Liver Transpl; 2007 Jun; 13(6):913-7. PubMed ID: 17539015
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical staining of liver grafts with a monoclonal antibody against HCV-Envelope 2 for recurrent hepatitis C after living donor liver transplantation.
Sadamori H; Yagi T; Iwagaki H; Matsuda H; Shinoura S; Umeda Y; Ohara N; Yanai H; Ogino T; Tanaka N
J Gastroenterol Hepatol; 2009 Apr; 24(4):574-80. PubMed ID: 19368635
[TBL] [Abstract][Full Text] [Related]
19. Differential allograft gene expression in acute cellular rejection and recurrence of hepatitis C after liver transplantation.
Sreekumar R; Rasmussen DL; Wiesner RH; Charlton MR
Liver Transpl; 2002 Sep; 8(9):814-21. PubMed ID: 12200784
[TBL] [Abstract][Full Text] [Related]
20. Clinical value and safety of liver biopsies in patients transplanted for hepatitis C virus-related end-stage liver disease.
Brauner C; Lankisch TO; Fytili P; Jaroszewicz J; Lehner F; Barg-Hock H; Klempnauer J; Jaeckel E; Manns MP; Wedemeyer H; Negm AA
Transpl Infect Dis; 2014 Dec; 16(6):958-67. PubMed ID: 25393916
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
